High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells

Area of Science:

• Cardiovascular Biology
• Cellular Biology
• Lipid Metabolism

Background:

• Endothelial progenitor cells (EPCs) are crucial for vascular repair and predict cardiovascular mortality.
• High-density lipoprotein (HDL) cholesterol has protective effects against cardiovascular events.
• The influence of HDL on EPC biology remains incompletely understood.

Purpose of the Study:

• To investigate the effects of HDL on EPC function and biology.
• To determine if HDL mediates vasculoprotective effects through EPC modulation.
• To explore the correlation between HDL and EPCs in patients with coronary artery disease.

Main Methods:

• Isolation and treatment of EPCs and human coronary artery endothelial cells (HCAEC) with HDL.
• Assays for cell differentiation (DiLDL/lectin staining), apoptosis (TUNEL, annexin V), and proliferation (BrdU).
• Flow chamber experiments for cell adhesion, flow cytometry for integrin expression (beta2, alpha4), and in vivo mouse models (re-endothelialization).

Main Results:

• HDL treatment enhanced EPC differentiation, inhibited apoptosis, and increased proliferation.
• HDL pre-incubation improved EPC adhesion to HCAEC, partly via beta2-integrin.
• HDL treatment of HCAEC reduced inflammatory cell adhesion.
• In vivo studies showed enhanced re-endothelialization in mice treated with HDL.
• A positive correlation was observed between circulating EPC and HDL levels in patients with coronary artery disease.

Conclusions:

• HDL significantly improves EPC function, including differentiation, survival, proliferation, and adhesion.
• HDL exerts vasculoprotective effects by enhancing EPC function and modulating endothelial cell responses.
• HDL may represent a therapeutic target for improving vascular health through EPC enhancement.